NANOZID

Marie Curie Individual Fellowship (2019-2022) 

Bacteria can invade immune cells or form biofilms and cause persistent infections. Such infections are difficult to treat because of the poor drug penetration. To overcome this, current studies indicate that liposomes can deliver antibiotics with better activity. However, liposomal products have low drug concentrations, poor drug retention, and rapid release. Therefore, a hybrid system comprising a DNA nanogel trapped within a liposome was developed for antibiotic delivery to address this problem.

This project has received funding from the European Union's Horizon 2020 Research & Innovation programme under grant agreement No. 834811

Website image.jpg